Ask AI
ProCE Banner Events

Share

Role of the Pharmacist in Timely and Optimal Management of Immune-Related Adverse Events

Join us for a 1.25-hour ACPE-certified webinar on managing immune-related adverse events. This event features expert recommendations on managing adverse events with immune checkpoint inhibitors when used alone or in combination with anti-VEGF therapies. Register now!

Pharmacists: 1.25 contact hours (0.125 CEUs)

Registration not open

Who Should Attend

The target audience is pharmacists, including community, outpatient, and ambulatory care pharmacists, who care for patients with and at risk for irAEs.

Time and location

Tuesday, April 18, 2023

12:00 PM - 1:15 PM Eastern Time (ET)

Virtual

Agenda

  • Welcome and Introductions
  • irAE Identification and Management in Patients Treated With ICI Therapy
  • AE Optimization for Current IO/Anti-VEGF Therapy Combinations
  • The Role of the Pharmacist in irAE Management and Patient Education
  • Question and Answer Session

CME/CE Info

Program Overview
This program will arm pharmacists with the knowledge and tools to identify and manage immune-related adverse events and to educate patients on the unique adverse events associated with immunotherapies. This program will consist of an 1.25-hour ACPE-certified webinar.

Goal Statement
The goal of this activity is to improve the knowledge and competence of pharmacists in identifying and managing irAEs to improve patient outcomes.

Target Audience
The target audience is pharmacists, including community, outpatient, and ambulatory care pharmacists, who care for patients with and at risk for irAEs. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Summarize the clinical efficacy and safety profiles associated with ICIs and ICI-targeted therapy combinations in various types of cancers
  • Develop a proactive management plan for early recognition and appropriate management of irAEs and associated ICI and ICI-targeted therapy combinations to support quality of life and continuation of treatment that incorporates collaboration among oncologists and physician subspecialists on the multidisciplinary cancer care team
  • Discern between immune-related and targeted therapy–associated adverse events to identify proper management approaches
  • Apply evidence-based and guidelines-based recommendations to the management of irAEs to optimize patient care
  • Communicate effectively to engage patients and caregivers in monitoring for the potential onset of irAEs to aid self-monitoring and AE reporting

Accreditation

CE Accreditation

Pharmacists

ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-23-009-L01-P has been assigned to this live application-based activity (initial release date 4/18/23). This activity is approved for 1.25 contact hours (0.125 CEUs) in states that recognize ACPE providers. This activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of the activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.

Disclosure
ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. Faculty disclosures will be provided prior to the start of the CE activity.

Acknowledgement

Provided by ProCE, LLC.

Supported by an educational grant from Merck Sharp & Dohme LLC.

Contact Information

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.